Pathogenesis of cystic fibrosis

Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide.

The European respiratory journal·2002

Itraconazole treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.

Allergy·2002

Microbial load of drinking water reservoir tributaries during extreme rainfall and runoff.

Applied and environmental microbiology·2002

Altered sialyl- and fucosyl-linkage on mucins in cystic fibrosis patients promotes formation of the sialyl-Lewis X determinant on salivary MUC-5B and MUC-7.

Pflugers Archiv : European journal of physiology·2002

Sulphation of the salivary mucin MG1 (MUC-5B) is not correlated to the degree of its sialylation and is unaffected by cystic fibrosis.

Pflugers Archiv : European journal of physiology·2002

Soil surface structure effect on isoproturon and diflufenican loss in runoff.

Journal of environmental quality·2002

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

An Intravesical Akkermansia muciniphila-Based Chemo-Immunotherapeutic Platform for Bladder Cancer.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

ETS1-EGR2 facilitates renal cell carcinoma progression by activating NOTCH signalling.

Clinical and translational medicine·2026

CLIC3 promotes lung cancer cell proliferation by regulating intracellular chloride and ROS levels.

Gene·2026

Aging's Competing Paradigms: Another Decade of Investigation into Damage-Driven versus Programmed Theories.

Ageing research reviews·2026

Imbalanced p53-RB signaling triggers cGAS-STING-mediated immune activation in early oral cancer development.

Oncogene·2026

Research advances in the recurrence patterns of glioblastoma.

Biochimica et biophysica acta. Reviews on cancer·2026

Related Experiment Videos

Pathogenesis of cystic fibrosis

Related Concept Videos

Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide.

Itraconazole treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.

Microbial load of drinking water reservoir tributaries during extreme rainfall and runoff.

Altered sialyl- and fucosyl-linkage on mucins in cystic fibrosis patients promotes formation of the sialyl-Lewis X determinant on salivary MUC-5B and MUC-7.

Sulphation of the salivary mucin MG1 (MUC-5B) is not correlated to the degree of its sialylation and is unaffected by cystic fibrosis.

Soil surface structure effect on isoproturon and diflufenican loss in runoff.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

An Intravesical Akkermansia muciniphila-Based Chemo-Immunotherapeutic Platform for Bladder Cancer.

ETS1-EGR2 facilitates renal cell carcinoma progression by activating NOTCH signalling.

CLIC3 promotes lung cancer cell proliferation by regulating intracellular chloride and ROS levels.

Aging's Competing Paradigms: Another Decade of Investigation into Damage-Driven versus Programmed Theories.

Imbalanced p53-RB signaling triggers cGAS-STING-mediated immune activation in early oral cancer development.

Research advances in the recurrence patterns of glioblastoma.

Related Experiment Videos

Pathogenesis of cystic fibrosis

Related Concept Videos

Related Articles